Ying E. Zhang, Ph.D.
Ying E. Zhang, Ph.D.
Senior Investigator

Center for Cancer Research
National Cancer Institute

Building 37, Room 2056B
Bethesda, MD 20892-4256
301-496-6454

Dr. Zhang's research focuses on understanding TGF-beta signaling and functions of ubiquitin E3 ligase Smurfs. She identified and characterized several key molecules in the TGF-beta signaling pathway, including Smads and Smurfs. Discoveries from her group generated mechanistic insight into how TGF-beta controls cellular responses through Smad-dependent and -independent pathways in normal and cancer cells. On the front of Smurf E3 ligases, their findings extended the function of Smurfs beyond TGF-beta pathway to genome stability and metastasis.

Areas of Expertise
1) Signaling Transduction 2) TGF-beta signaling 3) Protein kinases 4) Ubiquitination 5) Mouse models 6) Metastasis

TGF-beta and its related factors regulate a broad range of cellular functions, including proliferation, differentiation, apoptosis, migration and adhesion, and play very important roles in cancer and many other diseases. Our research focuses on three aspects of TGF-beta signaling in an attempt to gain further appreciation of its regulation, mechanisms of action and function in development and tumorigenesis. In order for proper TGF-beta signaling, the activity of Smad proteins is subject to stringent control, allowing alterations in the biological effects of ligands.  A key event that regulates R-Smad activity is phosphorylation.  Smad3 can be phosphorylated on cue of TGF-beta in the linker region in addition to the two C-terminal Ser residues. The linker sites are also phosphorylated by MAPK and CDK in response to mitotic signals.  Previously, we created mouse liver cancer models by forced expression of Smad3 tissue-specifically in the liver using the Tet-off inducible system. we found that up-regulating Smad3 protects the liver against carcinogenic insult, and demonstrated that this tumor-protective role is afforded by the ability of Smad3 to down-regulate Bcl-2 transcription via p38 kinase (Cancer Cell 2006). This finding offers a new insight into designing novel approaches for treating the liver cancer. Recently, we discovered that Smad3 not only regulates transcription but also alternative splicing in the nucleus, which facilitates cancer progression by stimulating EMT and invasion.

The second area of our research focused on the regulation of TGF-beta signaling modulators by ubiquitination, particularly the ubiquitin modification catalyzed by Smurf1 and Smurf2, which are HECT-domain E3 ligases.  Resorting to mouse genetic approaches, we generated knockout alleles of both Smurf1 and Smurf2 genes to address their roles under physiological conditions. We found that Smurf1 and Smurf2 have both common and unique functions during embryogenesis and in maintaining adult physiological homeostasis. Our earlier work on characterizing Smurf1 knockout mice revealed a novel function of Smurf1 in the regulation of osteoblast function and bone homeostasis (Cell 2005), suggesting that targeting Smurf1 may prove to be an effective strategy for treating age-related bone losses in osteoporosis. Our recent work on characterizing Smurf2 knockout mice clarified contradictory reports in the literature about Smurf regulation of TGF-beta signaling by showing that Smurf2 indeed has an inhibitory role, but it does so by attenuating Smad3 activity through mono-ubiquitination rather than promoting its degradation as previously reported (EMBO J 2011). Our study also led to an unexpected discovery of a previously unrecognized function of Smurf2 as a tumor suppressor that normally maintains genomic stability by controlling epigenetic landscape of histone modifications via RNF20 (Nature Medicine 2012).

Finally, although Smads are involved in most actions of the TGF-beta superfamily, activated TGF-beta receptors also transduce signals through other intracellular signaling pathways, especially those mediated by MAP kinases (EMBO J. 2012). The third area of research of our research focuses on the specific mechanism by which TGF-beta receptors activate non-Smad pathways, and the biological significance of these Smad-independent pathways in TGF-beta signaling. Previously, we identified TRAF6 as the mediator of Smad-independent signaling conduit that exerts its control of downstream gene expression via activation of the JNK/p38 kinase (Molecular Cell 2008). Currently we are working to identify other downstream mediators that are responsible for Smad-independent TGF-beta receptor signaling using SILAC-based proteomic approaches. These studies could uncover novel molecular mechanisms that account for a number of Smad-independent TGF-beta signaling responses, and shed light on a decade-old puzzle of why tumor cells, which often develop a resistance to TGF-beta-induced growth inhibition as they progress, can retain an otherwise functional TGF-beta signaling pathway.

Scientific Focus Areas:
Cancer Biology, Cell Biology, Developmental Biology, Molecular Biology and Biochemistry, Stem Cell Biology
Selected Key Publications
  1. Yu L, Hébert MC, Zhang YE.
    EMBO J. 21: 3749-59, 2002. [ Journal Article ]
  2. Yamashita M, Ying S, Zhang G, Li C, Cheng SY, Deng C, Zhang YE.
    Cell. 121: 101-13, 2005. [ Journal Article ]
  3. Yang YA, Zhang GM, Feigenbaum L, Zhang YE.
    Cancer Cell. 9: 445-57, 2006. [ Journal Article ]
  4. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE.
    Mol Cell. 31: 918-24, 2008. [ Journal Article ]
  5. Blank M, Tang Y, Yamashita M, Burkett SS, Cheng SY, Zhang YE.
    Nat. Med. 18: 227-34, 2012. [ Journal Article ]

Dr. Ying Zhang received her B.S. degree in Chemistry and M.S. degree in Biochemistry from Peking University, China. She obtained her Ph.D. degree from University of Wisconsin-Madison in 1995 and completed her postdoctoral training with Dr. Rik Derynck in University of California, San Francisco. She joined the Laboratory of Cellular and Molecular Biology in 2000 as a tenure-track investigator and became a senior investigator in 2007.

Position Number of Positions Contact E-mail Contact Name Contact Phone
Postdoctoral Fellow 1

zhangyin@mail.nih.gov

Dr. Ying Zhang 301-496-6454
Name Position
Mary Heller Research Chemist
Liu-Ya Tang Ph.D. Postdoctoral Fellow (CRTA)
Yi Tang Ph.D. Research Biologist
Adam Michael Thomas Ph.D. Postdoctoral Fellow (CRTA)
Veenu Tripathi Ph.D. Research Fellow
Jennifer Wang Summer Student
Xuan Xu Ph.D. Postdoctoral Fellow (Visiting)

Summary

Dr. Zhang's research focuses on understanding TGF-beta signaling and functions of ubiquitin E3 ligase Smurfs. She identified and characterized several key molecules in the TGF-beta signaling pathway, including Smads and Smurfs. Discoveries from her group generated mechanistic insight into how TGF-beta controls cellular responses through Smad-dependent and -independent pathways in normal and cancer cells. On the front of Smurf E3 ligases, their findings extended the function of Smurfs beyond TGF-beta pathway to genome stability and metastasis.

Areas of Expertise
1) Signaling Transduction 2) TGF-beta signaling 3) Protein kinases 4) Ubiquitination 5) Mouse models 6) Metastasis

Research

TGF-beta and its related factors regulate a broad range of cellular functions, including proliferation, differentiation, apoptosis, migration and adhesion, and play very important roles in cancer and many other diseases. Our research focuses on three aspects of TGF-beta signaling in an attempt to gain further appreciation of its regulation, mechanisms of action and function in development and tumorigenesis. In order for proper TGF-beta signaling, the activity of Smad proteins is subject to stringent control, allowing alterations in the biological effects of ligands.  A key event that regulates R-Smad activity is phosphorylation.  Smad3 can be phosphorylated on cue of TGF-beta in the linker region in addition to the two C-terminal Ser residues. The linker sites are also phosphorylated by MAPK and CDK in response to mitotic signals.  Previously, we created mouse liver cancer models by forced expression of Smad3 tissue-specifically in the liver using the Tet-off inducible system. we found that up-regulating Smad3 protects the liver against carcinogenic insult, and demonstrated that this tumor-protective role is afforded by the ability of Smad3 to down-regulate Bcl-2 transcription via p38 kinase (Cancer Cell 2006). This finding offers a new insight into designing novel approaches for treating the liver cancer. Recently, we discovered that Smad3 not only regulates transcription but also alternative splicing in the nucleus, which facilitates cancer progression by stimulating EMT and invasion.

The second area of our research focused on the regulation of TGF-beta signaling modulators by ubiquitination, particularly the ubiquitin modification catalyzed by Smurf1 and Smurf2, which are HECT-domain E3 ligases.  Resorting to mouse genetic approaches, we generated knockout alleles of both Smurf1 and Smurf2 genes to address their roles under physiological conditions. We found that Smurf1 and Smurf2 have both common and unique functions during embryogenesis and in maintaining adult physiological homeostasis. Our earlier work on characterizing Smurf1 knockout mice revealed a novel function of Smurf1 in the regulation of osteoblast function and bone homeostasis (Cell 2005), suggesting that targeting Smurf1 may prove to be an effective strategy for treating age-related bone losses in osteoporosis. Our recent work on characterizing Smurf2 knockout mice clarified contradictory reports in the literature about Smurf regulation of TGF-beta signaling by showing that Smurf2 indeed has an inhibitory role, but it does so by attenuating Smad3 activity through mono-ubiquitination rather than promoting its degradation as previously reported (EMBO J 2011). Our study also led to an unexpected discovery of a previously unrecognized function of Smurf2 as a tumor suppressor that normally maintains genomic stability by controlling epigenetic landscape of histone modifications via RNF20 (Nature Medicine 2012).

Finally, although Smads are involved in most actions of the TGF-beta superfamily, activated TGF-beta receptors also transduce signals through other intracellular signaling pathways, especially those mediated by MAP kinases (EMBO J. 2012). The third area of research of our research focuses on the specific mechanism by which TGF-beta receptors activate non-Smad pathways, and the biological significance of these Smad-independent pathways in TGF-beta signaling. Previously, we identified TRAF6 as the mediator of Smad-independent signaling conduit that exerts its control of downstream gene expression via activation of the JNK/p38 kinase (Molecular Cell 2008). Currently we are working to identify other downstream mediators that are responsible for Smad-independent TGF-beta receptor signaling using SILAC-based proteomic approaches. These studies could uncover novel molecular mechanisms that account for a number of Smad-independent TGF-beta signaling responses, and shed light on a decade-old puzzle of why tumor cells, which often develop a resistance to TGF-beta-induced growth inhibition as they progress, can retain an otherwise functional TGF-beta signaling pathway.

Scientific Focus Areas:
Cancer Biology, Cell Biology, Developmental Biology, Molecular Biology and Biochemistry, Stem Cell Biology

Publications

Selected Key Publications
  1. Yu L, Hébert MC, Zhang YE.
    EMBO J. 21: 3749-59, 2002. [ Journal Article ]
  2. Yamashita M, Ying S, Zhang G, Li C, Cheng SY, Deng C, Zhang YE.
    Cell. 121: 101-13, 2005. [ Journal Article ]
  3. Yang YA, Zhang GM, Feigenbaum L, Zhang YE.
    Cancer Cell. 9: 445-57, 2006. [ Journal Article ]
  4. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE.
    Mol Cell. 31: 918-24, 2008. [ Journal Article ]
  5. Blank M, Tang Y, Yamashita M, Burkett SS, Cheng SY, Zhang YE.
    Nat. Med. 18: 227-34, 2012. [ Journal Article ]

Biography

Dr. Ying Zhang received her B.S. degree in Chemistry and M.S. degree in Biochemistry from Peking University, China. She obtained her Ph.D. degree from University of Wisconsin-Madison in 1995 and completed her postdoctoral training with Dr. Rik Derynck in University of California, San Francisco. She joined the Laboratory of Cellular and Molecular Biology in 2000 as a tenure-track investigator and became a senior investigator in 2007.

Positions

Position Number of Positions Contact E-mail Contact Name Contact Phone
Postdoctoral Fellow 1

zhangyin@mail.nih.gov

Dr. Ying Zhang 301-496-6454

Team

Name Position
Mary Heller Research Chemist
Liu-Ya Tang Ph.D. Postdoctoral Fellow (CRTA)
Yi Tang Ph.D. Research Biologist
Adam Michael Thomas Ph.D. Postdoctoral Fellow (CRTA)
Veenu Tripathi Ph.D. Research Fellow
Jennifer Wang Summer Student
Xuan Xu Ph.D. Postdoctoral Fellow (Visiting)